The diagnostics sub-industry includes clinical laboratory testing, molecular diagnostics, genomic sequencing, and point-of-care testing companies. Quest Diagnostics and Laboratory Corporation process hundreds of millions of routine blood tests annually. Growth companies like Exact Sciences and Natera are pioneering liquid biopsy and non-invasive prenatal testing. AI-powered pathology is creating a new frontier in early disease detection, particularly for cancer.
Reimbursement coverage decisions from CMS and commercial payers are binary catalysts for growth-stage diagnostics companies. Watch test volume trends at Quest and Labcorp as economic leading indicators. Sequencing cost per genome determines the pace of genomics adoption.